Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

3.59
Delayed Data
As of 3:52pm ET
 -0.0101 / -0.28%
Today’s Change
2.81
Today|||52-Week Range
8.47
-24.58%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$66.5M

Company Description

Brainstorm Cell Therapeutics, Inc. operates as a biotechnology company, which develops innovative adult stem cell therapeutic products. It currently focuses on utilizing the patients own bone marrow stem cells to generate neuron-like cells that may provide an effective treatment initially for amyotrophic lateral sclerosis, Parkinson's disease, multiple sclerosis and spinal cord injury. The company was founded on September 22, 2000 and is headquartered in New York, NY.

Contact Information

Brainstorm Cell Therapeutics, Inc.
Three University Plaza Drive
Hackensack New Jersey 07601
P:(201) 488-0460
Investor Relations:

Employees

Shareholders

Mutual fund holders2.92%
Individual stakeholders12.66%
Other institutional12.11%

Top Executives

Anthony S. FiorinoChief Executive Officer
Chaim LebovitsPresident
Uri YablonkaChief Operating Officer & Director
Liat SossoverChief Financial Officer
Yael GothelfVice President-Scientific & Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account